STAT3 and extranodal nasal NK/T cell lymphoma: The pan-JAK inhibitor CP-690550 [85], the JAK1/3 inhibitor tofacitinib [87] and the selective STAT3 inhibitor WP1066 [86] could inhibit the proliferation and induce apoptosis in several NKTCL cell lines.